COVID summer uptick in US West and South
Analysis based on 6 articles · First reported Jul 24, 2026 · Last updated Jul 27, 2026
The summer uptick in COVID-19 may lead to increased demand for vaccines, testing, and treatments, benefiting healthcare companies. However, the low severity and declining death toll suggest minimal broader economic impact.
COVID-19 is on the upswing in United States — California and across a swath of the West and the South of the United States, indicating a seasonal summer uptick. The U.S. United States — Centers for Disease Control and Prevention estimates that COVID is growing in United States — California, United States — Texas, United States — Florida, United States — Missouri, United States — Alabama, United States — Oregon, United States — Utah, United States — Nevada, Mexico, and United States — Hawaii, though levels remain low. Test positivity rates and wastewater concentrations are increasing in several regions. For the week ending July 18, United States — California's test positivity rate was 3.4%, up from 1.15% a month ago. Hospitalization rates remain very low but are expected to rise. Health officials recommend updated vaccinations for high-risk groups. Worldwide, COVID activity was generally low, with increases in parts of Latin America, northern Europe, Africa, and Southeast Asia. Taiwan reported an increase and is monitoring activity in Japan, South Korea, China — Hong Kong, and China. COVID has become less deadly, with deaths declining from 385,676 in 2020 to 20,685 in 2025 in the U.S.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard